These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26263978)

  • 1. Progress and Prospects of Anti-HBV Gene Therapy Development.
    Maepa MB; Roelofse I; Ely A; Arbuthnot P
    Int J Mol Sci; 2015 Jul; 16(8):17589-610. PubMed ID: 26263978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing prospects for the future of using gene therapy to treat infections with hepatitis B virus and hepatitis C virus.
    Ely A; Arbuthnot P
    Discov Med; 2015 Sep; 20(109):137-43. PubMed ID: 26463095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
    He X; Li J; Wu J; Zhang M; Gao P
    Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA.
    Sekiba K; Otsuka M; Ohno M; Yamagami M; Kishikawa T; Suzuki T; Ishibashi R; Seimiya T; Tanaka E; Koike K
    World J Gastroenterol; 2018 Jun; 24(21):2261-2268. PubMed ID: 29881235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV.
    Peng C; Lu M; Yang D
    Virol Sin; 2015 Oct; 30(5):317-25. PubMed ID: 26511989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting hepatitis B virus cccDNA using CRISPR/Cas9.
    Kennedy EM; Kornepati AV; Cullen BR
    Antiviral Res; 2015 Nov; 123():188-92. PubMed ID: 26476375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
    Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
    Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas.
    Yang YC; Yang HC
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus.
    Ely A; Moyo B; Arbuthnot P
    Mol Ther; 2016 Apr; 24(4):671-7. PubMed ID: 26916283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments with advancing gene therapy to treat chronic infection with hepatitis B virus.
    Maepa MB; Jacobs R; van den Berg F; Arbuthnot P
    Curr Opin HIV AIDS; 2020 May; 15(3):200-207. PubMed ID: 32141890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.
    Nassal M
    Gut; 2015 Dec; 64(12):1972-84. PubMed ID: 26048673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA.
    Ohno M; Otsuka M; Kishikawa T; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jun; 21(23):7084-8. PubMed ID: 26109795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CccDNA persistence during natural evolution of chronic VHB infection.
    Caruntu FA; Molagic V
    Rom J Gastroenterol; 2005 Dec; 14(4):373-7. PubMed ID: 16400354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication.
    Takehara T; Suzuki T; Ohkawa K; Hosui A; Jinushi M; Miyagi T; Tatsumi T; Kanazawa Y; Hayashi N
    J Hepatol; 2006 Feb; 44(2):267-74. PubMed ID: 16226822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
    Palumbo GA; Scisciani C; Pediconi N; Lupacchini L; Alfalate D; Guerrieri F; Calvo L; Salerno D; Di Cocco S; Levrero M; Belloni L
    PLoS One; 2015; 10(11):e0142599. PubMed ID: 26580974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.
    Lutgehetmann M; Volz T; Köpke A; Broja T; Tigges E; Lohse AW; Fuchs E; Murray JM; Petersen J; Dandri M
    Hepatology; 2010 Jul; 52(1):16-24. PubMed ID: 20578126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
    Nash KL; Alexander GJ; Lever AM
    J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection.
    Kim JW; Lee SH; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH
    Intervirology; 2011; 54(6):316-25. PubMed ID: 21242658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting the RNA interference pathway to counter hepatitis B virus replication.
    Arbuthnot P; Carmona S; Ely A
    Liver Int; 2005 Feb; 25(1):9-15. PubMed ID: 15698393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection.
    Zhang Y; Mao R; Yan R; Cai D; Zhang Y; Zhu H; Kang Y; Liu H; Wang J; Qin Y; Huang Y; Guo H; Zhang J
    PLoS One; 2014; 9(10):e110442. PubMed ID: 25337821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.